Social networks
706 263 18,108Activities
Technologies
Entity types
Location
Neuroscience Center, Viikinkaari 4, 00790 Helsinki, Finland
Helsinki
Finland
Employees
Scale: 51-200
Estimated: 161
Engaged catalyst
16Added in Motherbase
2 years, 1 month agoGlobal experts in nanotechnology and drug particle engineering
Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services. Nanoform’s capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications.
We provide expert services in nanotechnology and drug particle engineering for the international pharma industry. Nanoform Finland Ltd has developed a proprietary technology called Controlled Expansion of Supercritical Solutions (CESS) that allows nanonization of drug particles.
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() UK Research and Innovation Public business cluster, Government Administration | UK Research and Innovation Public business cluster, Government Administration | Other 19 Nov 2019 | | |
![]() AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 1 Oct 2019 21 Nov 2023 | | |
![]() Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 28 Feb 2025 | | |
![]() Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Novo Nordisk Pharmaceutical, Pharmaceutical Manufacturing | Other 11 Jun 2024 | | |
![]() MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Other 3 Nov 2019 | | |
![]() Nasdaq Finance, Financial Services | Nasdaq Finance, Financial Services | Other 3 Jul 2020 12 Jun 2024 | | |